Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Global Human Oral Vaccine Market Growth 2024-2030

Report ID: 2898674 | Published Date: May 2025 | No. of Page: 142 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Human Oral Vaccine Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Human Oral Vaccine by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Human Oral Vaccine by Country/Region, 2019, 2023 & 2030

    2.2 Human Oral Vaccine Segment by Type

        2.2.1 Rotavirus Vaccine

        2.2.2 Cholera Vaccine

        2.2.3 Oral Polio Vaccine

        2.2.4 Other

    2.3 Human Oral Vaccine Sales by Type

        2.3.1 Global Human Oral Vaccine Sales Market Share by Type (2019-2024)

        2.3.2 Global Human Oral Vaccine Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Human Oral Vaccine Sale Price by Type (2019-2024)

    2.4 Human Oral Vaccine Segment by Application

        2.4.1 Child

        2.4.2 Aldult

    2.5 Human Oral Vaccine Sales by Application

        2.5.1 Global Human Oral Vaccine Sale Market Share by Application (2019-2024)

        2.5.2 Global Human Oral Vaccine Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Human Oral Vaccine Sale Price by Application (2019-2024)

3 Global Human Oral Vaccine by Company

    3.1 Global Human Oral Vaccine Breakdown Data by Company

        3.1.1 Global Human Oral Vaccine Annual Sales by Company (2019-2024)

        3.1.2 Global Human Oral Vaccine Sales Market Share by Company (2019-2024)

    3.2 Global Human Oral Vaccine Annual Revenue by Company (2019-2024)

        3.2.1 Global Human Oral Vaccine Revenue by Company (2019-2024)

        3.2.2 Global Human Oral Vaccine Revenue Market Share by Company (2019-2024)

    3.3 Global Human Oral Vaccine Sale Price by Company

    3.4 Key Manufacturers Human Oral Vaccine Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Human Oral Vaccine Product Location Distribution

        3.4.2 Players Human Oral Vaccine Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Oral Vaccine by Geographic Region

    4.1 World Historic Human Oral Vaccine Market Size by Geographic Region (2019-2024)

        4.1.1 Global Human Oral Vaccine Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Human Oral Vaccine Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Human Oral Vaccine Market Size by Country/Region (2019-2024)

        4.2.1 Global Human Oral Vaccine Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Human Oral Vaccine Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Human Oral Vaccine Sales Growth

    4.4 APAC Human Oral Vaccine Sales Growth

    4.5 Europe Human Oral Vaccine Sales Growth

    4.6 Middle East & Africa Human Oral Vaccine Sales Growth

5 Americas

    5.1 Americas Human Oral Vaccine Sales by Country

        5.1.1 Americas Human Oral Vaccine Sales by Country (2019-2024)

        5.1.2 Americas Human Oral Vaccine Revenue by Country (2019-2024)

    5.2 Americas Human Oral Vaccine Sales by Type

    5.3 Americas Human Oral Vaccine Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Human Oral Vaccine Sales by Region

        6.1.1 APAC Human Oral Vaccine Sales by Region (2019-2024)

        6.1.2 APAC Human Oral Vaccine Revenue by Region (2019-2024)

    6.2 APAC Human Oral Vaccine Sales by Type

    6.3 APAC Human Oral Vaccine Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Human Oral Vaccine by Country

        7.1.1 Europe Human Oral Vaccine Sales by Country (2019-2024)

        7.1.2 Europe Human Oral Vaccine Revenue by Country (2019-2024)

    7.2 Europe Human Oral Vaccine Sales by Type

    7.3 Europe Human Oral Vaccine Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Human Oral Vaccine by Country

        8.1.1 Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024)

    8.2 Middle East & Africa Human Oral Vaccine Sales by Type

    8.3 Middle East & Africa Human Oral Vaccine Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Human Oral Vaccine

    10.3 Manufacturing Process Analysis of Human Oral Vaccine

    10.4 Industry Chain Structure of Human Oral Vaccine

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Human Oral Vaccine Distributors

    11.3 Human Oral Vaccine Customer

12 World Forecast Review for Human Oral Vaccine by Geographic Region

    12.1 Global Human Oral Vaccine Market Size Forecast by Region

        12.1.1 Global Human Oral Vaccine Forecast by Region (2025-2030)

        12.1.2 Global Human Oral Vaccine Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Human Oral Vaccine Forecast by Type

    12.7 Global Human Oral Vaccine Forecast by Application

13 Key Players Analysis

    13.1 Merck

        13.1.1 Merck Company Information

        13.1.2 Merck Human Oral Vaccine Product Portfolios and Specifications

        13.1.3 Merck Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Merck Main Business Overview

        13.1.5 Merck Latest Developments

    13.2 GSK

        13.2.1 GSK Company Information

        13.2.2 GSK Human Oral Vaccine Product Portfolios and Specifications

        13.2.3 GSK Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 GSK Main Business Overview

        13.2.5 GSK Latest Developments

    13.3 Sanofi

        13.3.1 Sanofi Company Information

        13.3.2 Sanofi Human Oral Vaccine Product Portfolios and Specifications

        13.3.3 Sanofi Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Sanofi Main Business Overview

        13.3.5 Sanofi Latest Developments

    13.4 Lanzhou Institute

        13.4.1 Lanzhou Institute Company Information

        13.4.2 Lanzhou Institute Human Oral Vaccine Product Portfolios and Specifications

        13.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Lanzhou Institute Main Business Overview

        13.4.5 Lanzhou Institute Latest Developments

    13.5 Serum Institute

        13.5.1 Serum Institute Company Information

        13.5.2 Serum Institute Human Oral Vaccine Product Portfolios and Specifications

        13.5.3 Serum Institute Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Serum Institute Main Business Overview

        13.5.5 Serum Institute Latest Developments

    13.6 Valneva

        13.6.1 Valneva Company Information

        13.6.2 Valneva Human Oral Vaccine Product Portfolios and Specifications

        13.6.3 Valneva Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Valneva Main Business Overview

        13.6.5 Valneva Latest Developments

    13.7 Shanghai United Cell

        13.7.1 Shanghai United Cell Company Information

        13.7.2 Shanghai United Cell Human Oral Vaccine Product Portfolios and Specifications

        13.7.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 Shanghai United Cell Main Business Overview

        13.7.5 Shanghai United Cell Latest Developments

    13.8 Bibcol

        13.8.1 Bibcol Company Information

        13.8.2 Bibcol Human Oral Vaccine Product Portfolios and Specifications

        13.8.3 Bibcol Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.8.4 Bibcol Main Business Overview

        13.8.5 Bibcol Latest Developments

    13.9 PaxVax

        13.9.1 PaxVax Company Information

        13.9.2 PaxVax Human Oral Vaccine Product Portfolios and Specifications

        13.9.3 PaxVax Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.9.4 PaxVax Main Business Overview

        13.9.5 PaxVax Latest Developments

    13.10 Vabiotech

        13.10.1 Vabiotech Company Information

        13.10.2 Vabiotech Human Oral Vaccine Product Portfolios and Specifications

        13.10.3 Vabiotech Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.10.4 Vabiotech Main Business Overview

        13.10.5 Vabiotech Latest Developments

    13.11 Tiantan Biological

        13.11.1 Tiantan Biological Company Information

        13.11.2 Tiantan Biological Human Oral Vaccine Product Portfolios and Specifications

        13.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.11.4 Tiantan Biological Main Business Overview

        13.11.5 Tiantan Biological Latest Developments

    13.12 EuBiologics

        13.12.1 EuBiologics Company Information

        13.12.2 EuBiologics Human Oral Vaccine Product Portfolios and Specifications

        13.12.3 EuBiologics Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.12.4 EuBiologics Main Business Overview

        13.12.5 EuBiologics Latest Developments

    13.13 Panacea Biotec Ltd

        13.13.1 Panacea Biotec Ltd Company Information

        13.13.2 Panacea Biotec Ltd Human Oral Vaccine Product Portfolios and Specifications

        13.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.13.4 Panacea Biotec Ltd Main Business Overview

        13.13.5 Panacea Biotec Ltd Latest Developments

    13.14 Bio-Med

        13.14.1 Bio-Med Company Information

        13.14.2 Bio-Med Human Oral Vaccine Product Portfolios and Specifications

        13.14.3 Bio-Med Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.14.4 Bio-Med Main Business Overview

        13.14.5 Bio-Med Latest Developments

    13.15 Halfkin Bio-Pharmaceuticals

        13.15.1 Halfkin Bio-Pharmaceuticals Company Information

        13.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolios and Specifications

        13.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)

        13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview

        13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

    Table 1. Human Oral Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Human Oral Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of Rotavirus Vaccine

    Table 4. Major Players of Cholera Vaccine

    Table 5. Major Players of Oral Polio Vaccine

    Table 6. Major Players of Other

    Table 7. Global Human Oral Vaccine Sales by Type (2019-2024) & (K Units)

    Table 8. Global Human Oral Vaccine Sales Market Share by Type (2019-2024)

    Table 9. Global Human Oral Vaccine Revenue by Type (2019-2024) & ($ million)

    Table 10. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)

    Table 11. Global Human Oral Vaccine Sale Price by Type (2019-2024) & (US$/Unit)

    Table 12. Global Human Oral Vaccine Sales by Application (2019-2024) & (K Units)

    Table 13. Global Human Oral Vaccine Sales Market Share by Application (2019-2024)

    Table 14. Global Human Oral Vaccine Revenue by Application (2019-2024)

    Table 15. Global Human Oral Vaccine Revenue Market Share by Application (2019-2024)

    Table 16. Global Human Oral Vaccine Sale Price by Application (2019-2024) & (US$/Unit)

    Table 17. Global Human Oral Vaccine Sales by Company (2019-2024) & (K Units)

    Table 18. Global Human Oral Vaccine Sales Market Share by Company (2019-2024)

    Table 19. Global Human Oral Vaccine Revenue by Company (2019-2024) ($ Millions)

    Table 20. Global Human Oral Vaccine Revenue Market Share by Company (2019-2024)

    Table 21. Global Human Oral Vaccine Sale Price by Company (2019-2024) & (US$/Unit)

    Table 22. Key Manufacturers Human Oral Vaccine Producing Area Distribution and Sales Area

    Table 23. Players Human Oral Vaccine Products Offered

    Table 24. Human Oral Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 25. New Products and Potential Entrants

    Table 26. Mergers & Acquisitions, Expansion

    Table 27. Global Human Oral Vaccine Sales by Geographic Region (2019-2024) & (K Units)

    Table 28. Global Human Oral Vaccine Sales Market Share Geographic Region (2019-2024)

    Table 29. Global Human Oral Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 30. Global Human Oral Vaccine Revenue Market Share by Geographic Region (2019-2024)

    Table 31. Global Human Oral Vaccine Sales by Country/Region (2019-2024) & (K Units)

    Table 32. Global Human Oral Vaccine Sales Market Share by Country/Region (2019-2024)

    Table 33. Global Human Oral Vaccine Revenue by Country/Region (2019-2024) & ($ millions)

    Table 34. Global Human Oral Vaccine Revenue Market Share by Country/Region (2019-2024)

    Table 35. Americas Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

    Table 36. Americas Human Oral Vaccine Sales Market Share by Country (2019-2024)

    Table 37. Americas Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)

    Table 38. Americas Human Oral Vaccine Revenue Market Share by Country (2019-2024)

    Table 39. Americas Human Oral Vaccine Sales by Type (2019-2024) & (K Units)

    Table 40. Americas Human Oral Vaccine Sales by Application (2019-2024) & (K Units)

    Table 41. APAC Human Oral Vaccine Sales by Region (2019-2024) & (K Units)

    Table 42. APAC Human Oral Vaccine Sales Market Share by Region (2019-2024)

    Table 43. APAC Human Oral Vaccine Revenue by Region (2019-2024) & ($ Millions)

    Table 44. APAC Human Oral Vaccine Revenue Market Share by Region (2019-2024)

    Table 45. APAC Human Oral Vaccine Sales by Type (2019-2024) & (K Units)

    Table 46. APAC Human Oral Vaccine Sales by Application (2019-2024) & (K Units)

    Table 47. Europe Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

    Table 48. Europe Human Oral Vaccine Sales Market Share by Country (2019-2024)

    Table 49. Europe Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)

    Table 50. Europe Human Oral Vaccine Revenue Market Share by Country (2019-2024)

    Table 51. Europe Human Oral Vaccine Sales by Type (2019-2024) & (K Units)

    Table 52. Europe Human Oral Vaccine Sales by Application (2019-2024) & (K Units)

    Table 53. Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

    Table 54. Middle East & Africa Human Oral Vaccine Sales Market Share by Country (2019-2024)

    Table 55. Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)

    Table 56. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country (2019-2024)

    Table 57. Middle East & Africa Human Oral Vaccine Sales by Type (2019-2024) & (K Units)

    Table 58. Middle East & Africa Human Oral Vaccine Sales by Application (2019-2024) & (K Units)

    Table 59. Key Market Drivers & Growth Opportunities of Human Oral Vaccine

    Table 60. Key Market Challenges & Risks of Human Oral Vaccine

    Table 61. Key Industry Trends of Human Oral Vaccine

    Table 62. Human Oral Vaccine Raw Material

    Table 63. Key Suppliers of Raw Materials

    Table 64. Human Oral Vaccine Distributors List

    Table 65. Human Oral Vaccine Customer List

    Table 66. Global Human Oral Vaccine Sales Forecast by Region (2025-2030) & (K Units)

    Table 67. Global Human Oral Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 68. Americas Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)

    Table 69. Americas Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 70. APAC Human Oral Vaccine Sales Forecast by Region (2025-2030) & (K Units)

    Table 71. APAC Human Oral Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 72. Europe Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)

    Table 73. Europe Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 74. Middle East & Africa Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)

    Table 75. Middle East & Africa Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 76. Global Human Oral Vaccine Sales Forecast by Type (2025-2030) & (K Units)

    Table 77. Global Human Oral Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 78. Global Human Oral Vaccine Sales Forecast by Application (2025-2030) & (K Units)

    Table 79. Global Human Oral Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 80. Merck Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 81. Merck Human Oral Vaccine Product Portfolios and Specifications

    Table 82. Merck Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 83. Merck Main Business

    Table 84. Merck Latest Developments

    Table 85. GSK Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 86. GSK Human Oral Vaccine Product Portfolios and Specifications

    Table 87. GSK Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 88. GSK Main Business

    Table 89. GSK Latest Developments

    Table 90. Sanofi Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 91. Sanofi Human Oral Vaccine Product Portfolios and Specifications

    Table 92. Sanofi Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 93. Sanofi Main Business

    Table 94. Sanofi Latest Developments

    Table 95. Lanzhou Institute Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 96. Lanzhou Institute Human Oral Vaccine Product Portfolios and Specifications

    Table 97. Lanzhou Institute Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 98. Lanzhou Institute Main Business

    Table 99. Lanzhou Institute Latest Developments

    Table 100. Serum Institute Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 101. Serum Institute Human Oral Vaccine Product Portfolios and Specifications

    Table 102. Serum Institute Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 103. Serum Institute Main Business

    Table 104. Serum Institute Latest Developments

    Table 105. Valneva Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 106. Valneva Human Oral Vaccine Product Portfolios and Specifications

    Table 107. Valneva Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 108. Valneva Main Business

    Table 109. Valneva Latest Developments

    Table 110. Shanghai United Cell Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 111. Shanghai United Cell Human Oral Vaccine Product Portfolios and Specifications

    Table 112. Shanghai United Cell Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 113. Shanghai United Cell Main Business

    Table 114. Shanghai United Cell Latest Developments

    Table 115. Bibcol Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 116. Bibcol Human Oral Vaccine Product Portfolios and Specifications

    Table 117. Bibcol Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 118. Bibcol Main Business

    Table 119. Bibcol Latest Developments

    Table 120. PaxVax Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 121. PaxVax Human Oral Vaccine Product Portfolios and Specifications

    Table 122. PaxVax Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 123. PaxVax Main Business

    Table 124. PaxVax Latest Developments

    Table 125. Vabiotech Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 126. Vabiotech Human Oral Vaccine Product Portfolios and Specifications

    Table 127. Vabiotech Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 128. Vabiotech Main Business

    Table 129. Vabiotech Latest Developments

    Table 130. Tiantan Biological Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 131. Tiantan Biological Human Oral Vaccine Product Portfolios and Specifications

    Table 132. Tiantan Biological Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 133. Tiantan Biological Main Business

    Table 134. Tiantan Biological Latest Developments

    Table 135. EuBiologics Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 136. EuBiologics Human Oral Vaccine Product Portfolios and Specifications

    Table 137. EuBiologics Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 138. EuBiologics Main Business

    Table 139. EuBiologics Latest Developments

    Table 140. Panacea Biotec Ltd Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 141. Panacea Biotec Ltd Human Oral Vaccine Product Portfolios and Specifications

    Table 142. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 143. Panacea Biotec Ltd Main Business

    Table 144. Panacea Biotec Ltd Latest Developments

    Table 145. Bio-Med Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 146. Bio-Med Human Oral Vaccine Product Portfolios and Specifications

    Table 147. Bio-Med Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 148. Bio-Med Main Business

    Table 149. Bio-Med Latest Developments

    Table 150. Halfkin Bio-Pharmaceuticals Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors

    Table 151. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolios and Specifications

    Table 152. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 153. Halfkin Bio-Pharmaceuticals Main Business

    Table 154. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

    Figure 1. Picture of Human Oral Vaccine

    Figure 2. Human Oral Vaccine Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Human Oral Vaccine Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Human Oral Vaccine Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Human Oral Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of Rotavirus Vaccine

    Figure 10. Product Picture of Cholera Vaccine

    Figure 11. Product Picture of Oral Polio Vaccine

    Figure 12. Product Picture of Other

    Figure 13. Global Human Oral Vaccine Sales Market Share by Type in 2023

    Figure 14. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)

    Figure 15. Human Oral Vaccine Consumed in Child

    Figure 16. Global Human Oral Vaccine Market: Child (2019-2024) & (K Units)

    Figure 17. Human Oral Vaccine Consumed in Aldult

    Figure 18. Global Human Oral Vaccine Market: Aldult (2019-2024) & (K Units)

    Figure 19. Global Human Oral Vaccine Sales Market Share by Application (2023)

    Figure 20. Global Human Oral Vaccine Revenue Market Share by Application in 2023

    Figure 21. Human Oral Vaccine Sales Market by Company in 2023 (K Units)

    Figure 22. Global Human Oral Vaccine Sales Market Share by Company in 2023

    Figure 23. Human Oral Vaccine Revenue Market by Company in 2023 ($ Million)

    Figure 24. Global Human Oral Vaccine Revenue Market Share by Company in 2023

    Figure 25. Global Human Oral Vaccine Sales Market Share by Geographic Region (2019-2024)

    Figure 26. Global Human Oral Vaccine Revenue Market Share by Geographic Region in 2023

    Figure 27. Americas Human Oral Vaccine Sales 2019-2024 (K Units)

    Figure 28. Americas Human Oral Vaccine Revenue 2019-2024 ($ Millions)

    Figure 29. APAC Human Oral Vaccine Sales 2019-2024 (K Units)

    Figure 30. APAC Human Oral Vaccine Revenue 2019-2024 ($ Millions)

    Figure 31. Europe Human Oral Vaccine Sales 2019-2024 (K Units)

    Figure 32. Europe Human Oral Vaccine Revenue 2019-2024 ($ Millions)

    Figure 33. Middle East & Africa Human Oral Vaccine Sales 2019-2024 (K Units)

    Figure 34. Middle East & Africa Human Oral Vaccine Revenue 2019-2024 ($ Millions)

    Figure 35. Americas Human Oral Vaccine Sales Market Share by Country in 2023

    Figure 36. Americas Human Oral Vaccine Revenue Market Share by Country in 2023

    Figure 37. Americas Human Oral Vaccine Sales Market Share by Type (2019-2024)

    Figure 38. Americas Human Oral Vaccine Sales Market Share by Application (2019-2024)

    Figure 39. United States Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 40. Canada Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 41. Mexico Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 42. Brazil Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 43. APAC Human Oral Vaccine Sales Market Share by Region in 2023

    Figure 44. APAC Human Oral Vaccine Revenue Market Share by Regions in 2023

    Figure 45. APAC Human Oral Vaccine Sales Market Share by Type (2019-2024)

    Figure 46. APAC Human Oral Vaccine Sales Market Share by Application (2019-2024)

    Figure 47. China Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 48. Japan Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 49. South Korea Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 50. Southeast Asia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 51. India Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 52. Australia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 53. China Taiwan Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 54. Europe Human Oral Vaccine Sales Market Share by Country in 2023

    Figure 55. Europe Human Oral Vaccine Revenue Market Share by Country in 2023

    Figure 56. Europe Human Oral Vaccine Sales Market Share by Type (2019-2024)

    Figure 57. Europe Human Oral Vaccine Sales Market Share by Application (2019-2024)

    Figure 58. Germany Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 59. France Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 60. UK Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 61. Italy Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 62. Russia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 63. Middle East & Africa Human Oral Vaccine Sales Market Share by Country in 2023

    Figure 64. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country in 2023

    Figure 65. Middle East & Africa Human Oral Vaccine Sales Market Share by Type (2019-2024)

    Figure 66. Middle East & Africa Human Oral Vaccine Sales Market Share by Application (2019-2024)

    Figure 67. Egypt Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 68. South Africa Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 69. Israel Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Turkey Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 71. GCC Country Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)

    Figure 72. Manufacturing Cost Structure Analysis of Human Oral Vaccine in 2023

    Figure 73. Manufacturing Process Analysis of Human Oral Vaccine

    Figure 74. Industry Chain Structure of Human Oral Vaccine

    Figure 75. Channels of Distribution

    Figure 76. Global Human Oral Vaccine Sales Market Forecast by Region (2025-2030)

    Figure 77. Global Human Oral Vaccine Revenue Market Share Forecast by Region (2025-2030)

    Figure 78. Global Human Oral Vaccine Sales Market Share Forecast by Type (2025-2030)

    Figure 79. Global Human Oral Vaccine Revenue Market Share Forecast by Type (2025-2030)

    Figure 80. Global Human Oral Vaccine Sales Market Share Forecast by Application (2025-2030)

    Figure 81. Global Human Oral Vaccine Revenue Market Share Forecast by Application (2025-2030)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Merck"|||"GSK"|||"Sanofi"|||"Lanzhou Institute"|||"Serum Institute"|||"Valneva"|||"Shanghai United Cell"|||"Bibcol"|||"PaxVax"|||"Vabiotech"|||"Tiantan Biological"|||"EuBiologics"|||"Panacea Biotec Ltd"|||"Bio-Med"|||"Halfkin Bio-Pharmaceuticals"
Frequently Asked Questions
Human Oral Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Oral Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Oral Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports